INVESTORS

MusclePharm Schedules 2017 First Quarter Financial Results

Download PDF

DENVER, May 3, 2017 /PRNewswire/ -- MusclePharm Corporation (OTCQB: MSLP), a scientifically-driven, performance-lifestyle sports nutrition company, will report its financial results for the first quarter ended March 31, 2017 on Wednesday, May 10, 2017, after the U.S. markets close.

The Company will also host a conference call at 4:30 p.m. Eastern Time on Wednesday, May 10, 2017 to review its financial results and business outlook.

2017 First Quarter Conference Call Information

When: Wednesday, May 10, 2017
Time: 4:30 p.m. Eastern Time
Phone:
1-888-539-3678 (domestic)
1-719-457-2604 (international)
Conference ID: 7192811

A live webcast will be available online on MusclePharm's website at http://ir.musclepharmcorp.com/, where it will be archived for one year.

An audio replay of the conference call will be available through midnight May 24, 2017 by dialing 1-844-512-2921 from the U.S. or Canada, or 1-412-317-6671 from international locations, Conference ID: 7192811.

About MusclePharm Corporation

MusclePharm® is a scientifically-driven, performance lifestyle company that develops, manufactures, markets and distributes branded nutritional supplements. The Company offers a range of powders, capsules, tablets and gels. Its portfolio of recognized brands includes MusclePharm® Sport Series, Black Label and Core Series, FitMiss™, as well as Natural Series which was launched in 2017. These products are available in more than 120 countries and over 50,000 retail outlets worldwide. The clinically-proven supplements are developed through a six-stage research process utilizing the expertise of leading nutritional scientists, doctors and universities. MusclePharm is the innovator of the sports nutrition industry. For more information, visit http://www.musclepharm.com. To sign up to receive MusclePharm news via email, please visit http://ir.musclepharmcorp.com/email-alerts.

Contact:
Anne Donohoe
PR for MusclePharm
adonohoe@kcsa.com
212.896.1265

Phil Carlson / Elizabeth Barker
IR for MusclePharm
pcarlson@kcsa.com / ebarker@kcsa.com
212.896.1233 / 212.896.1203

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/musclepharm-schedules-2017-first-quarter-financial-results-300450557.html

SOURCE MusclePharm Corporation


MusclePharm_Corp_bg_tradeshow